Bombesin receptor-mediated imaging and cytotoxicity: review and current status
about
Insights into bombesin receptors and ligands: Highlighting recent advancesBombesin analogue-mediated delivery preferentially enhances the cytotoxicity of a mitochondria-disrupting peptide in tumor cellsHigh-Throughput Approaches to the Development of Molecular Imaging Agents.Bombesin receptor subtype 3 as a potential target for obesity and diabetes.Fluorescent, Plasmonic, and Radiotherapeutic Properties of the 177Lu-Dendrimer-AuNP-Folate-Bombesin Nanoprobe Located Inside Cancer CellsRhodamine-marked bombesin: a novel means for prostate cancer fluorescence imaging.Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members.Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancerProspective of ⁶⁸Ga-radiopharmaceutical development.Peptide-based imaging agents for cancer detection.Radiolabeled bombesin derivatives for preclinical oncological imaging.Imaging agents for the chemokine receptor 4 (CXCR4).Click-to-Chelate: development of technetium and rhenium-tricarbonyl labeled radiopharmaceuticals.Radiolabeled peptide-receptor ligands in tumor imaging.Design and evaluation of radiolabeled tracers for tumor imaging.Drug delivery and release systems for targeted tumor therapy.Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.Towards the elaboration of new gold-based optical theranostics.The clinical role of multimodality imaging in the detection of prostate cancer recurrence after radical prostatectomy and radiation therapy: past, present, and futureA new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.A fast tumor-targeting near-infrared fluorescent probe based on bombesin analog for in vivo tumor imaging.The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell lineHow gastrin-releasing peptide receptor (GRPR) and αvβ3 integrin expression reflect reorganization features of tumors after hyperthermia treatments.1,2,3-Triazoles as amide bond mimics: triazole scan yields protease-resistant peptidomimetics for tumor targeting.Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates.Multimodal molecular 3D imaging for the tumoral volumetric distribution assessment of folate-based biosensors.Gastrin-releasing peptide promotes the migration of vascular smooth muscle cells through upregulation of matrix metalloproteinase-2 and -9.Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26.MA-NOTMP: A Triazacyclononane Trimethylphosphinate Based Bifunctional Chelator for Gallium Radiolabelling of Biomolecules.The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see forever....Glycated 99m Tc-Tricarbonyl-Labeled Peptide Conjugates for Tumor Targeting by "Click-to-Chelate".A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting.Neuropeptide G Protein-Coupled Receptors as Oncotargets.
P2860
Q28081153-71296AE8-45C6-48F8-96CA-061935935B20Q28486692-6AE0993C-3803-4860-B1E3-FAF6FF172DDAQ30275493-542E5BC5-6A75-4573-9BA2-B3577CA22AD2Q33637115-8FB14FCB-9212-4D75-AE32-59B7740AE23BQ33793282-92437E51-8253-4136-ACAF-792E4A6A41AAQ34752361-3B5072CB-245D-4ABD-82C7-77D4185DFDBBQ35154092-4108FAFC-D4AF-4A52-B9E0-F6A8FA28FE93Q36208460-3B5ABEE7-D05E-44B5-A1DE-E88FF25956CEQ36834005-C9B17130-0F21-4F44-9212-61AB1A63A0CCQ37435222-C94DDB8E-855C-44D2-AC10-310D599A124CQ37585965-DA2F4DC7-1866-452F-8BD9-AADA0ED2B195Q37674035-81EFD0E4-4899-42F4-9C31-DF866C8A3709Q38022430-68C2CCA0-7479-4CDE-AE63-36690945BEBCQ38088564-482F31BA-EF1A-4668-B076-5BC48D6F92D6Q38088748-C27A22EC-E18E-4642-A75F-4186F896371DQ38137253-80D46072-26E4-4A36-B701-8B991AFDFF1EQ38363691-DF826B9C-2FA3-41E8-9D8F-8570A1FB700CQ38776596-C37F5778-98FC-4AFB-BFF0-E712692B4946Q38876206-9FE8A323-5F80-4F78-A80B-1021E4D762F9Q38925590-5606EB1A-2FF0-433A-95DA-A93F86009642Q38930321-8B9F50EA-D572-4956-AF6E-45C182C62DF4Q38956835-7D716747-34F3-4AF6-9988-04D207F4A8B5Q39015002-16849A74-6CC5-49B2-81CA-8BA3D6AB428DQ39016753-5A1B96E7-4B54-4134-97D6-26731D687392Q39024393-F20E553B-0104-44C7-95C8-F4421DE61C36Q39162754-66807869-BFC1-4C34-AA4B-6FE1B47A7AB9Q39378866-3CC685BA-115A-418B-93F2-1D7700B3FE15Q39418313-6E4EB2E3-20F8-44DC-8E9E-654AF2CC16AAQ41191885-1A4C411D-2A6C-49A1-AB69-57DECD8EC469Q44277672-B0D28F6F-0194-4825-A8E0-1E26143FC6F5Q45354634-13A65B7D-8007-4453-A584-AAB10DB44ACBQ47592063-765E379B-DF1D-45B7-A3F8-354B1D377F7DQ47609299-E4888FCD-2F02-45D7-A4BE-C85DFAC3660FQ48098858-484FE3A5-05A4-46FF-8DB2-1BAAC2990010Q48149537-6430EB1D-AFF9-4D8B-A37B-47999B377BD8Q48827044-E4EF7593-C72B-424A-A4C4-DC71D5F43947Q48918816-EB34D23B-9F27-40B9-9B48-F9EFF2A066FAQ50149052-1EBA00E0-ADBB-4D5E-A27A-CBF4741FBA8CQ55098217-1DE5FA06-A2DE-4CE4-B92F-1004A7778E15Q55709770-954BA5EF-9A55-451B-AD57-6783FD4BDBE4
P2860
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@ast
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@en
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@nl
type
label
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@ast
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@en
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@nl
prefLabel
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@ast
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@en
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@nl
P2093
P2860
P1476
Bombesin receptor-mediated imaging and cytotoxicity: review and current status
@en
P2093
Alessia Di Florio
Robert T Jensen
Terry W Moody
Veronica Sancho
P2860
P304
P356
10.2174/156720111793663624
P577
2011-01-01T00:00:00Z